[The importance of clinical laboratory data in the differential diagnosis of group hepatitis B diseases].
Group disease with hepatitis B (or A against the background of chronic HBsAg carrier state) may be diagnosed (or excluded) on the basis of high (or low) detectability of HBsAg in patients with jaundice. Perfection of epidemiological diagnosis is possible with implementation of indication of not less than three immunological markers: HBsAg, IgM anti-Hbs, IgM anti-HAV.
Orgel'
M Ia
MIa
Tychinskiĭ
N V
NV
Rogotskaia
L T
LT
Reznikov
A P
AP
Muliar
I S
IS
Sapego
Zh K
ZhK
D002353:Carrier State / Q000175:diagnosis / Q000453:epidemiology; D002648:Child; D003937:Diagnosis, Differential; D004196:Disease Outbreaks; D006506:Hepatitis A / Q000175:diagnosis / Q000453:epidemiology; D006508:Hepatitis Antibodies / Q000097:blood; D006509:Hepatitis B / Q000175:diagnosis* / Q000453:epidemiology; D006510:Hepatitis B Antibodies / Q000097:blood; D006512:Hepatitis B Core Antigens / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006507:Hepatovirus / Q000276:immunology; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis; D014455:Ukraine / Q000453:epidemiology
D006508:Hepatitis Antibodies; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D007075:Immunoglobulin M
Znachenie kliniko-laboratornykh dannykh v differentsial'noĭ diagnostike gruppovykh zabolevaniĭ gepatitom B.